Skip to content
A
  • HomeHome
  • SearchSearch
  • AskAsk
  • SavedSaved

Maria Luckevich

Novo Nordisk Canada (Canada)1 paperORCID 0000-0002-4308-2574 ↗OpenAlex ↗

Papers

Value in HealthIn silico·30 Sep

Estimating the Wider Societal Impact of Semaglutide Across Multiple Indications in Canada: an Economic Evaluation

  • News
  • Trials
  • Topics
  • Evidence
  • Stats
  • Updates
  • API
  • Plus

© 2026 AgingResearch.News

PrivacyTerms

    News

    See all →

    Semaglutide extends lifespan in aged female mice, a Nature study reports↗

    ResearchLifespan.com

    Idiopathic pulmonary fibrosis therapy shifts blood aging clocks in a new study↗

    ResearchLifespan.com

    Fight Aging! discusses brain PD-L1 inhibition and contextual mTOR targeting↗

    ResearchFight Aging!

    Trials

    See all →

    Registered2 Oct 2026

    Safety and Preliminary Efficacy of Adipose-Derived Stem Cell Secretome in Frailty (VinVital)

    Phase 1 · Vinmec Research Institute of Stem Cell and Gene Technology

    Registered1 Oct 2026

    Functional Mobility and Resistance Exercise for Postmenopausal Females With Type 1 Diabetes

    Institut de Recherches Cliniques de Montreal

    Registered25 Sept 2026

    Effect of LiFE-SePBT on Postural Stability in Community-dwelling Older Adults: an Assessor-blinded Randomised Controlled Trial

    The Hong Kong Polytechnic University

    Trending

    Evidence →
    1. Intervention · 73 papersExercise
    2. Gene · 26 papersAPOE
    3. Disease · 126 papersType 2 diabetes
    4. Pathway · 127 papersInflammation
    5. Biomarker · 38 papersHbA1c
    6. Intervention · 37 papersGLP-1 receptor agonists

    Topics

    See all →
    • Brain aging262
    • Cellular senescence56
    • GLP-1 drugs56
    • Inflammaging42
    • Aging clocks41
    • Mitochondria17
    • Dietary restriction13
    • mTOR & rapamycin5
    • NAD+ & sirtuins3
    • Partial reprogramming1
    • Stats
    • Updates
    • API
    • Plus
    • Privacy
    • Terms
    • © 2026 AgingResearch.News